Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
17.11.25
/
50%
€20.43
Target price
17.11.26
€26.71
Performance (%)
-6.41%
Price
10.04.26
€18.54
Summary
This prediction is currently active. With a performance of -6.41%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 17.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -3.689% | -3.689% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $33.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.87
04.03.26
04.03.26
€29.31
04.03.27
04.03.27
-3.75%
10.04.26
10.04.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
2.01%
10.04.26
10.04.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
-7.33%
10.04.26
10.04.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
-3.86%
10.04.26
10.04.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25